Featured In Research and Innovation
Pegylated interferon lambda (PEG-IFN-lambda) is a potent antiviral cytokine that acts to generate an antiviral state within many cell types. In this Q&A, Raymond Chung, MD, explains what is currently known about PEG-IFN-lambda therapy and why he is excited about its potential to treat COVID-19 patients.
Featured In OB/GYN
Massachusetts General Hospital physicians suggest that if COVID-19 in pregnant women is not improved by treatment, then delivery may be considered even in the absence of obstetric indications.
Featured In Neuroscience
Patients are opting not to seek medical care due to fears of COVID-19. Massachusetts General Hospital has prepared for this pandemic and taken every precaution to accept stroke patients in the emergency department. Researchers are identifying the links between infection and stroke risk.
We are currently recruiting HIV + adults who are interested in participating in a study assessing heart health through new, noninvasive ways of looking at the heart vessels through imaging.